IP Library Granted Patent US 7,230,004
Granted Patent B2
US 7,230,004 · App. 11/213,534 · Granted Jun 12, 2007

Cyclopamine analogues and methods of use thereof

Assignee: Infinity Discovery, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,230,004
App. No.
11/213,534
Granted
Jun 12, 2007
Kind
B2
Abstract

The present invention provides compositions and methods for modulating smoothened-dependent pathway activation. The present invention provides analogs of cyclopamine that can be used to counteract the phenotypic effects of unwanted activation of a hedgehog pathway, such as resulting from hedgehog gain-of-function, Ptc loss-of-function or smoothened gain-of-function mutations. The compounds of the present invention are particularly useful in treating cancers.

Claims (110)

1. A compound of Formula 1:

or a pharmaceutically acceptable salt thereof;

wherein each R 1 and R 8 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, halide, sulfhydryl, alkylthio, arylthio, aralkylthio, hydroxyl, alkoxyl, aryloxy, acyloxy, amino, alkylamino, arylamino, acylamino, aralkylamino, nitro, acylthio, carboxamide, sulfonamide, sulfate, —OP(L)(OR 20 ) 2 , —X—C(L)—R 21 or —X—C(L)-X—R 21 ;

wherein R 1 may also be a sugar;

each X is independently O or NR wherein R is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl or aralkyl;

L is O or S;

R 2 and R 9 are independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, nitrile, aralkyl, alkoxyl, aryloxy, acyloxy, carboxyl, halide, sulfhydryl, alkylthio, arylthio, aralkylthio, hydroxyl, amino, alkylamino, arylamino, acylamino, aralkylamino, heteroaryl, or heteroaralkyl;

each R 5 and R 11 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, alkoxyl, aryloxy, acyloxy, halide, hydroxyl, amino, alkylamino, arylamino, acylamino, aralkylamino, alkylseleno, aralkylseleno, arylseleno, alkylthio, aralkylthio, arylthio, heteroaryl, or heteroaralkyl;

each R 3 , R 4 , R 6 , R 7 , R 13 and R 14 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, alkoxyl, aryloxy, acyloxy, halide, hydroxyl, amino, alkylamino, arylamino, acylamino, aralkylamino, heteroaryl, or heteroaralkyl;

or R 1 and R 2 taken together and/or R 8 and R 9 taken together, along with the carbon to which they are bonded, form —(C═O)—, —(C═S)—, —(C═N(OR 20 ))—, —(C═N(R 20 ))—, —(C═N(N(R 20 )(R 20 ))), or form an optionally substituted 3–8 membered ring containing up to two heteroatoms selected from N, O, and S; or

R 4 and R 5 taken together and/or R 5 and R 6 taken together and/or R 10 and R 11 taken together form a double bond or form a group represented by 1b

wherein Z is NR 21 , O, or C(R 23 )(R 23 );

R 12 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, hydroxyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, alkoxyl, —C(O)R 21 , —CO 2 R 21 , —SO 2 R 21 , —C(O)N(R 21 )(R 21 ), —[C(R 21 ) 2 ] q —R 21 , —[(W)—N(R 21 )C(O)] q R 21 , —[(W)—C(O)] q R 21 , —[(W)—C(O)O] q R 21 , —[(W)—OC(O)] q R 21 , —[(W)—SO 2 ] q R 21 , —[(W)—N(R 21 )SO 2 ] q R 21 , —[(W)—C(O)N(R 21 )] q R 21 , —[(W)—O] q R 21 , —[(W)—N(R 21 )] q R 21 , or —[(W)—S] q R 21 ;

wherein each W is independently a diradical, and q is 1, 2, 3, 4, 5, or 6;

R 15 , R 16 , and R 17 are independently H, alkoxyl, aryloxy, acyloxy, halide, hydroxyl, amino, alkylamino, arylamino, acylamino, aralkylamino; or R 15 and R 16 taken together, along with the carbon to which they are bonded, form —C(O)— or —C(S)—;

R 18 and R 19 are independently H, alkyl, araalkyl, halide, amido, or ester;

each R 20 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; or any two occurrences of R 20 on the same substituent can be taken together to form a 4–8 membered optionally substituted ring;

each R 21 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl or —[C(R 20 ) 2 ] p —R 25 wherein p is 0–6; or any two occurrences of R 21 on the same substituent can be taken together to form a 4–8 membered optionally substituted ring which contains 0–3 heteroatoms selected from N, O, S, and P;

each R 23 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, halide, alkoxyl, aryloxy, acyloxy, silyloxy, nitrile, —C(O)R 21 , —CO 2 R 21 , —SO 2 R 21 , and —C(O)N(R 21 ) 2 ;

each R 25 is independently H, hydroxyl, acylamino, —N(R 20 )COR 20 , —N(R 20 )C(O)OR 20 , —N(R 20 )SO 2 (R 20 ), —COR 20 N(R 20 ) 2 , —OC(O)R 20 N(R 20 )(R 20 ), —SO 2 N(R 20 )(R 20 ), —N(R 20 )(R 20 ), —COOR 20 , —C(O)N(OH)(R 21 ), —OS(O) 2 OR 20 , —S(O) 2 OR 20 , —OP(L)(OR 20 )(OR 20 ), —NP(O)(OR 20 )(OR 20 ), or —P(O)(OR 20 )(OR 20 ).

2. The compound of claim 1 , wherein R 13 , R 14 , R 15 , R 16 , and R 17 are hydrogen.

3. The compound of claim 1 , wherein R 1 is hydroxyl, sugar, —OP(L)(OR 20 ) 2 , —X—C(L)—R 21 , or —X—C(L)—X—R 21 ; or R 1 and R 2 taken together, along with the carbon to which they are bonded, form —C(O)—.

4. The compound of claim 1 , wherein R 4 and R 5 taken together form a double bond.

5. The compound of claim 4 , wherein R 1 and R 2 taken together, along with the carbon to which they are bonded, form —C(O)—.

6. The compound of claim 1 , wherein R 1 is hydroxyl and R 2 is H.

7. The compound of claim 6 , wherein R 5 and R 6 taken together form a double bond;

or R 5 and R 6 taken together form a group represented by 1b;

wherein:

Z is C(R 23 )(R 23 ).

8. The compound of claim 1 , wherein R 10 and R 11 taken together form a double bond; or R 10 and R 11 taken together form a group represented by 1b;

wherein:

Z is C(R 23 )(R 23 ).

9. The compound of claim 1 , wherein R 5 and R 6 taken together form a double bond and R 10 and R 11 taken together form a double bond.

10. The compound of claim 5 , wherein R 10 and R 11 taken together form a double bond; or R 10 and R 11 taken together form a group represented by 1b;

wherein:

Z is C(R 23 )(R 23 ).

11. The compound of claim 6 , wherein R 10 and R 11 taken together form a double bond; or R 10 and R 11 taken together form a group represented by 1b;

wherein:

Z is C(R 23 )(R 23 ).

12. The compound of claim 1 , wherein R 8 and R 9 are hydrogen; or R 8 and R 9 taken together, along with the carbon to which they are bonded, is —C(O)—.

13. The compound of claim 1 , wherein R 12 is H, alkyl, cycloalkyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, hydroxyl, alkoxyl, —[(W)—N(R 21 )C(O)] q R 21 , —[(W)—N(R 21 )SO 2 ] q R 21 , —[(W)—C(O)N(R 21 )] q R 21 , —[(W)—O] q R 21 , —[(W)—C(O)] q R 21 , or —[(W)—C(O)O] q R 21 .

14. The compound of claim 2 , wherein R 12 is H, alkyl, cycloalkyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, hydroxyl, alkoxyl, —[(W)—N(R 21 )C(O)] q R 21 , —[(W)—N(R 21 )SO 2 ] q R 21 , —[(W)—C(O)N(R 21 )] q R 21 , —[(W)—O] q R 21 , —[(W)—C(O)] q R 21 , or —[(W)—C(O)O] q R 21 .

15. The compound of claim 5 , wherein R 12 is H, alkyl, cycloalkyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, hydroxyl, alkoxyl, —[(W)—N(R 21 )C(O)] q R 21 , —[(W)—N(R 21 )SO 2 ] q R 21 , —[(W)—C(O)N(R 21 )] q R 21 , —[(W)—O] q R 21 , —[(W)—C(O)] q R 21 , or —[(W)—C(O)O] q R 21 .

16. The compound of claim 6 , wherein R 12 is H, alkyl, cycloalkyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, hydroxyl, alkoxyl, —[(W)—N(R 21 )C(O)] q R 21 , —[(W)—N(R 21 )SO 2 ] q R 21 , —[(W)—C(O)N(R 21 )] q R 21 , —[(W)—O] q R 21 , —[(W)—C(O)] q R 21 , or —[(W)—C(O)O] q R 21 .

17. A compound of the formula:

wherein:

R 12 is H, alkyl, aryl, cycloalkyl, heterocycloalkyl, hydroxyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, alkoxyl, —C(O)R 21 , —CO 2 R 21 , —SO 2 R 21 , —C(O)N(R 21 )(R 21 ), —[C(R 21 ) 2 ] p —R 21 , —[(W)—N(R 21 )C(O)] q R 21 , —[(W)—C(O)] q R 21 , —[(W)—C(O)O] q R 21 , —[(W)—OC(O)] q R 21 , —[(W)—SO 2 ] q R 21 , —[(W)—N(R 21 )SO 2 ] q R 21 , —[(W)—C(O)N(R 21 )] q R 21 , —[(W)—O] q R 21 , —[(W)—N(R 21 )] q R 21 , or —[(W)—S] q R 21 ;

wherein each W is independently a diradical;

q is 1, 2, 3, 4, 5, or 6;

each R 20 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; or any two occurrences of R 20 on the same substituent can be taken together to form a 4–8 membered optionally substituted ring containing 0–3 heteroatoms selected from O, N, S, and P;

each R 21 is independently H, alkyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl or —[C(R 20 ) 2 ] p —R 25 wherein p is 0–6; or any two occurrences of R 21 on the same substituent can be taken together to form a 4–8 membered optionally substituted ring containing 0–3 heteroatoms selected from O, N, S, and P;

each R 25 is independently H, hydroxyl, acylamino, —N(R 20 )COR 20 , —N(R 20 )C(O)OR 20 , —N(R 20 )SO 2 (R 20 ), —COR 20 N(R 20 ) 2 , —OC(O)R 20 N(R 20 )(R 20 ), —SO 2 N(R 20 )(R 20 ), —N(R 20 )(R 20 ), —COOR 20 , —C(O)N(OH)(R 20 ), —OS(O) 2 OR 19 , —S(O) 2 OR 20 , —OP(O)(OR 20 )(OR 20 ), —NP(O)(OR 20 )(OR 20 ), or —P(O)(OR 20 )(OR 20 ).

18. A compound selected from the group consisting of:

19. The compound of claim 1 , which has the formula:

20. A compound of Formula 2:

or a pharmaceutically acceptable salt thereof;

wherein each R 1 and R 8 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, halide, sulfhydryl, alkylthio, arylthio, aralkylthio, hydroxyl, alkoxyl, aryloxy, acyloxy, amino, alkylamino, arylamino, acylamino, aralkylamino, nitro, acylthio, carboxamide, sulfonamide, sulfate, —OP(L)(OR 21 ) 2 , —X—C(L)—R 21 or —X—C(L)—X—R 21 ;

wherein R 1 may also be a sugar;

each X is independently O or NR wherein R is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl or aralkyl;

L is O or S;

R 2 and R 9 are independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, nitrile, aralkyl, alkoxyl, aryloxy, acyloxy, carboxyl, halide, sulfhydryl, alkylthio, arylthio, aralkylthio, hydroxyl, amino, alkylamino, arylamino, acylamino, aralkylamino, heteroaryl, or heteroaralkyl;

each R 5 and R 11 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, alkoxyl, aryloxy, acyloxy, halide, hydroxyl, amino, alkylamino, arylamino, acylamino, aralkylamino, alkylseleno, aralkylseleno, arylseleno, alkylthio, aralkylthio, arylthio, heteroaryl, or heteroaralkyl;

each R 3 , R 4 , R 6 , R 7 , R 13 and R 14 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, alkoxyl, aryloxy, acyloxy, halide, hydroxyl, amino, alkylamino, arylamino, acylamino, aralkylamino, heteroaryl, or heteroaralkyl;

or R 1 and R 2 taken together and/or R 8 and R 9 taken together, along with the carbon to which they are bonded, form —(C═O)—, —(C═S)—, —(C═N(OR 20 ))—, —(C═N(R 20 ))—, —(C═N(N(R 20 )(R 20 ))), or form an optionally substituted 3–8 membered ring containing up to two heteroatoms selected from N, O, and S; or

R 4 and R 5 taken together and/or R 5 and R 6 taken together and/or R 10 and R 11 taken together form a double bond or form a group represented by 1b

wherein Z is NR 21 , or C(R 23 )(R 23 );

R 12 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, hydroxyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, alkoxyl, —C(O)R 21 , —CO 2 R 21 , —SO 2 R 21 , —C(O)N(R 21 )(R 21 ), —[C(R 21 ) 2 ] q —R 21 , —[(W)—N(R 21 )C(O)] q R 21 , —[(W)—C(O)] q R 21 , —[(W)—C(O)O] q R 21 , [(W)—OC(O)] q R 21 , —[(W)—SO 2 ] q R 21 , —[(W)—N(R 21 )SO 2 ] q R 21 , —[(W)—C(O)N(R 21 )] q R 21 , —[(W)—O] q R 21 , —[(W)—N(R 21 )] q R 21 , or —[(W)—S] q R 21 ;

wherein each W is independently a diradical, and q is 1, 2, 3, 4, 5, or 6;

R 15 , R 16 , and R 17 are independently H, alkoxyl, aryloxy, acyloxy, halide, hydroxyl, amino, alkylamino, arylamino, acylamino, aralkylamino; or R 15 and R 16 taken together, along with the carbon to which they are bonded, form —C(O)— or —C(S)—;

R 18 and R 19 are independently H, alkyl, araalkyl, halide, amido, or ester;

each R 20 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; or any two occurrences of R 20 on the same substituent can be taken together to form a 4–8 membered optionally substituted ring;

each R 21 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl or —[C(R 20 ) 2 ] p —R 25 wherein p is 0–6; or any two occurrences of R 21 on the same substituent can be taken together to form a 4–8 membered optionally substituted ring which contains up two heteroatoms selected from N, O, S, and P;

each R 23 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, halide, alkoxyl, aryloxy, acyloxy, silyloxy, nitrile, —C(O)R 21 , —CO 2 R 21 , —SO 2 R 21 , and —C(O)N(R 21 ) 2 ;

each R 25 is independently H, hydroxyl, acylamino, —N(R 20 )COR 20 , —N(R 20 )C(O)OR 20 , —N(R 20 )S 2 (R 20 ), —COR 20 N(R 20 ) 2 , —OC(O)R 20 N(R 20 )(R 20 ), —SO 2 N(R 20 )(R 20 ), —N(R 20 )(R 20 ), —COOR 20 , —C(O)N(OH)(R 21 ), —OS(O) 2 OR 20 , —S(O) 2 OR 20 , —OP(L)(OR 20 )(OR 20 ), —NP(O)(OR 20 )(OR 20 ), or —P(O)(OR 20 )(OR 20 ).

provided that there is at least one group represented by formula 1b on said compound of formula 2.

21. The compound of claim 20 , wherein R 13 , R 14 , R 15 , R 16 , and R 17 are hydrogen.

22. The compound of claim 20 , wherein R 1 is hydroxyl, sugar, —OP(L)(OR 20 ) 2 , —X—C(L)-R 21 , or —X—C(L)—X—R 21 ; or R 1 and R 2 taken together, along with the carbon to which they are bonded, form —C(O)—.

23. The compound of claim 20 , wherein R 4 and R 5 taken together form a double bond.

24. The compound of claim 23 , wherein R 1 and R 2 taken together, along with the carbon to which they are bonded, form —C(O)—.

25. The compound of claim 20 , wherein R 1 is hydroxyl and R 2 is H.

26. The compound of claim 25 , wherein R 5 and R 6 taken together form a double bond; or R 5 and R 6 taken together form a group represented by 1b;

wherein:

Z is C(R 23 )(R 23 ).

27. The compound of claim 20 , wherein R 10 and R 11 taken together form a double bond; or R 10 and R 11 taken together form a group represented by 1b;

wherein:

Z is C(R 23 )(R 23 ).

28. The compound of claim 20 , wherein R 5 and R 6 taken together and R 10 and R 11 taken together form a group represented by 1b;

wherein:

Z is C(R 23 )(R 23 ).

29. The compound of claim 24 , wherein R 10 and R 11 taken together form a double bond; or R 10 and R 11 taken together form a group represented by 1b;

wherein:

Z is C(R 23 )(R 23 ).

30. The compound of claim 25 , wherein R 10 and R 11 taken together form a double bond; or R 10 and R 11 taken together form a group represented by 1b;

wherein:

Z is C(R 23 )(R 23 ).

31. The compound of claim 20 , wherein R 8 and R 9 are hydrogen; or R 8 and R 9 taken together, along with the carbon to which they are bonded, is —C(O)—.

32. The compound of claim 20 , wherein R 12 is H, alkyl, cycloalkyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, —[(W)—N(R 21 )C(O)] q R 21 , —[(W)—N(R 21 )SO 2 ] q R 21 , —[(W)—C(O)N(R 21 )] q R 21 , —[(W)—O] q R 21 , —[(W)—C(O)] q R 21 , or —[(W)—C(O)O] q R 21 .

33. The compound of claim 21 , wherein R 12 is H, alkyl, cycloalkyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, hydroxyl, alkoxyl, —[(W)—N(R 21 )C(O)] q R 21 , —[(W)—N(R 21 )SO 2 ] q R 21 , —[(W)—C(O)N(R 21 )] q R 21 , —[(W)—O] q R 21 , —[(W)—C(O)] q R 21 , or —[(W)—C(O)O] q R 21 .

34. The compound of claim 24 , wherein R 12 is H, alkyl, cycloalkyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, hydroxyl, alkoxyl, —[(W)—N(R 21 )C(O)] q R 21 , —[(W)—N(R 21 )SO 2 ] q R 21 , —[(W)—C(O)N(R 21 )] q R 21 , —[(W)—O] q R 21 , —[(W)—C(O)] q R 21 , or —[(W)—C(O)O] q R 21 .

35. The compound of claim 25 , wherein R 12 is H, alkyl, cycloalkyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, hydroxyl, alkoxyl, —[(W)—N(R 21 )C(O)] q R 21 , —[(W)—N(R 21 )SO 2 ] q R 21 , —[(W)—C(O)N(R 21 )] q R 21 , —[(W)—O] q R 21 , —[(W)—C(O)] q R 21 , or —[(W)—C(O)O] q R 21 .

36. A compound of the formula:

wherein:

R 12 is H, alkyl, aryl, cycloalkyl, heterocycloalkyl, hydroxyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, alkoxyl, —C(O)R 21 , —CO 2 R 21 , —SO 2 R 21 , —C(O)N(R 21 )(R 21 ), —[C(R 21 ) 2 ] p —R 21 , —[(W)—N(R 21 )C(O)] q R 21 , —[(W)—C(O)] q R 21 , —[(W)—C(O)O] q R 21 , —[(W)—OC(O)] q R 21 , —[(W)—SO 2 ] q R 21 , —[(W)—N(R 21 )SO 2 ] q R 21 , —[(W)—C(O)N(R 21 )] q R 21 , —[(W)—O] q R 21 , —[(W)—N(R 21 )] q R 21 , or —[(W)—S] q R 21 ;

q is 1, 2, 3, 4, 5, or 6;

each R 20 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; or any two occurrences of R 20 on the same substituent can be taken together to form a 4–8 membered optionally substituted ring containing 0–3 heteroatoms selected from O, N, S, and P;

each R 21 is independently H, alkyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl or —[C(R 20 ) 2 ] p —R 25 wherein p is 0–6; or any two occurrences of R 21 on the same substituent can be taken together to form a 4–8 membered optionally substituted ring containing 0–3 heteroatoms selected from O, N, S, and P;

each R 25 is independently H, hydroxyl, acylamino, —N(R 20 )COR 20 , —N(R 20 )C(O)OR 20 , —N(R 20 )SO 2 (R 20 ), —COR 20 N(R 20 ) 2 , —OC(O)R 20 N(R 20 )(R 20 ), —SO 2 N(R 20 )(R 20 ), —N(R 20 )(R 20 ), —COOR 20 , —C(O)N(OH)(R 21 ), —OS(O) 2 OR 19 , —S(O) 2 OR 20 , —OP(O)(OR 20 )(OR 20 ), —NP(O)(OR 20 )(OR 20 ), or —P(O)(OR 20 )(OR 20 ).

37. A compound selected from the group consisting of:

38. The compound of claim 20 , which has the formula:

39. A pharmaceutical composition, comprising a compound of claim 1 ; and a pharmaceutically acceptable excipient.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2020
From: INFINITY PHARMACEUTICALS, INC.
To: ROYALTY SECURITY, LLC
Reel/Frame 051519/0511 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2012
From: INFINITY DISCOVERY, INC.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 027648/0451 →
CHANGE OF NAME Recorded Aug 5, 2008
From: INFINITY PHARMACEUTICALS, INC.
To: INFINITY DISCOVERY, INC.
Reel/Frame 021339/0289 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2005
From: ADAMS, JULIAN; CASTRO, ALFREDO C.; FOLEY, MICHAEL A.; JANARDANAN NAIR, SOMARAJAN NAIR; NEVALAINEN, MARTA; PORTER, JAMES R.; TREMBLAY, MARTIN R.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 017080/0237 →
Continuity (5)
Provisional Application 6068316900 · May 19, 2005
Provisional Application 6062567600 · Nov 5, 2004
Provisional Application 6061717000 · Oct 8, 2004
Provisional Application 6060502000 · Aug 27, 2004
Related Publication 20060074030A1 · Apr 6, 2006